Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets

Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.

Chinese Insurer Sues Korean Firm Over Failed Deal for 15 U.S. Luxury Hotels

The global nature of the Covid-19 crisis is clear in a filing in Delaware chancery court, as financing for flashy real estate deals has dried up.

Let This IPO-Maker Make You Some Dividend Cash

Sutter Rock is a rare find worth checking out for dividend seekers -- and it's got a 13% dividend yield.

Crimson Wine Group Might Ultimately Make an Interesting Acquisition Candidate

CWGL is a member of my Triple-Net Active Versus Passive experiment.

What's Not to Like About the New Raytheon Technologies?

This is day one of trading for a vastly changed company - Raytheon - now merged with United Technologies to form Raytheon Technologies.

A Cypress/Infineon Deal Rejection Could Have Broader Chip M&A Repercussions

Should U.S. regulators block the Cypress/Infineon deal on national security grounds, China could respond by blocking M&A transactions involving U.S. acquirers.

Nokia and its Peers Have Good Reasons to Explore M&A

With telecom capex still under pressure amid 5G rollout delays, equipment suppliers might find consolidation to be the best path to profit growth.

If You Invest in Small-Cap Stocks, You've Got to Learn to Deal With Setbacks

Tivity Health's big price drop serves as an example of the thought process an investor must go through when a holding takes an unexpected hit.

Morgan Stanley Jumps Into the Deep End With E*Trade Purchase

What I suspect is that the stock price of MS will likely trade in a relatively tight range.

There Are No Signs That the Mood of the Market Has Shifted

The pockets of strong trading action in individual stocks illustrates an appetite for speculative action.